SCHEMBL6300423

SCHEMBL6300423

CCOC(=O)c1c(-c2cc(Cl)ccc2F)[nH]c2ccccc2c1=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.55
PTGES O14684 5/20 0.55
CSF1R P07333 1/20 0.53
NPC1 O15118 1/20 0.52
KDM4E B2RXH2 3/20 0.51
TP53 P04637 1/20 0.49
ALDH1A1 P00352 4/20 0.49
HPGD P15428 3/20 0.49
HSD17B10 Q99714 2/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
CASP1 P29466 1/20 0.49
CYP1A2 P05177 1/20 0.47
XBP1 P17861 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6295733 0.89 ALOX5 (0.58) ALOX5PTGESCSF1RNPC1KDM4E
SCHEMBL8515925 0.83 ALOX5 (0.64) ALOX5PTGESCSF1RNPC1KDM4E
SCHEMBL6300618 0.83 ALOX5 (0.60) ALOX5PTGESCSF1RKDM4ETP53
SCHEMBL6295725 0.81 CSF1R (0.71) ALOX5PTGESCSF1RKDM4EALDH1A1
SCHEMBL6295738 0.80 ALOX5 (0.60) ALOX5PTGESNPC1KDM4EALDH1A1
SCHEMBL6295739 0.80 ALOX5 (0.58) ALOX5PTGESCSF1RKDM4ETP53
SCHEMBL6295718 0.80 ALOX5 (0.62) ALOX5PTGESCSF1RNPC1KDM4E
SCHEMBL6300573 0.79 ALOX5 (0.58) ALOX5PTGESCSF1RNPC1KDM4E
SCHEMBL6300719 0.79 ALDH1A1 (0.67) ALOX5CSF1RNPC1KDM4EALDH1A1
SCHEMBL6295920 0.78 ALOX5 (0.57) ALOX5PTGESNPC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK ALOX5 3056/4885PTGES 2572/4885CSF1R 3253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.